CRISPR Therapeutics AG (CRSP): A Bull Case Theory

We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on wallstreetbets Subreddit Page by MADD-Scientis. In this article, we will summarize the bulls’ thesis on CRSP. CRISPR Therapeutics AG (CRSP)’s share was trading at $40.97 as of March 18th. CRSP’s trailing and forward P/E were 22.55 and 23.36 respectively according to Yahoo Finance.

Intellia Therapeutics (NTLA): Among The Small–Cap Stocks Insiders Are Selling Recently

A lab scientist peering into a microscope focused on gene editing technology.

CRISPR Therapeutics (CRSP) is a pioneering biotech firm...